Discover iCELLis™ 1000 - the next generation disposable bioreactor - at Interphex 2010 in New York. Click on the link below to learn more and watch the new video of iCELLis™ 1000
for additional information
Meet us at the 11th Symposium on Computer Applications in Biotechnology (CAB) in Leuven, Belgium, from July 7th to 9th 2010.
for additional information
iCELLis™ , fixed bed disposable technology.
for additional information
Originality
In October 2006, Artelis signed a Joint Development Agreement with ATMI LifeSciences to develop a range of single-use disposable bioreactors for use in the biotechnology industry.
To develop this new technology, Artelis and ATMI LifeSciences are also supported in their partnership by the company Pierre-Guérin Biolafitte, which specialises in devising monitoring systems.
Applications
This range of bioreactors is aimed at:
- manufacturers of human, viral and recombinant vaccines in the 200-1,000 litres range
- manufacturers of animal (mainly viral) vaccines in the same range
- manufacturers of clinical batches in the field of monoclonal antibodies (anti-cancer treatments) in the 500-1,000 litres range
- development laboratories in the above industries using the 25-100-litres range
Advantages
Today there are various solutions for creating cell cultures within single-use systems. However, when choosing an industrial bioreactor there are very few credible options.
The Artelis bioreactor is different to other reactors currently available on the market:
- it can create both suspended and adherent cell cultures
- it offers a professional monitoring system comparable to that of a conventional bioreactor
- unlimited range
- it is flexible and very small
Go to market
The Nucleo™ bioreactor with a capacity of 50-1000 liters is now available and will be presented at Interphex in March 2008.